AU612854B2 – Novel neplanocin derivatives
– Google Patents
AU612854B2 – Novel neplanocin derivatives
– Google Patents
Novel neplanocin derivatives
Info
Publication number
AU612854B2
AU612854B2
AU36517/89A
AU3651789A
AU612854B2
AU 612854 B2
AU612854 B2
AU 612854B2
AU 36517/89 A
AU36517/89 A
AU 36517/89A
AU 3651789 A
AU3651789 A
AU 3651789A
AU 612854 B2
AU612854 B2
AU 612854B2
Authority
AU
Australia
Prior art keywords
novel
neplanocin derivatives
neplanocin
derivatives
novel neplanocin
Prior art date
1988-06-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU36517/89A
Other versions
AU3651789A
(en
Inventor
Esa T. Jarvi
James R. Mccarthy
Nellikunja J. Prakash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1988-06-20
Filing date
1989-06-16
Publication date
1991-07-18
1989-06-16
Application filed by Merrell Dow Pharmaceuticals Inc
filed
Critical
Merrell Dow Pharmaceuticals Inc
1989-12-21
Publication of AU3651789A
publication
Critical
patent/AU3651789A/en
1991-07-18
Application granted
granted
Critical
1991-07-18
Publication of AU612854B2
publication
Critical
patent/AU612854B2/en
2009-06-16
Anticipated expiration
legal-status
Critical
Status
Ceased
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D473/00—Heterocyclic compounds containing purine ring systems
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/12—Antivirals
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P35/00—Antineoplastic agents
C—CHEMISTRY; METALLURGY
C07—ORGANIC CHEMISTRY
C07D—HETEROCYCLIC COMPOUNDS
C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 – C07D463/00
C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 – C07D463/00 in which the condensed system contains two hetero rings
C07D471/04—Ortho-condensed systems
AU36517/89A
1988-06-20
1989-06-16
Novel neplanocin derivatives
Ceased
AU612854B2
(en)
Applications Claiming Priority (2)
Application Number
Priority Date
Filing Date
Title
US20924588A
1988-06-20
1988-06-20
US209245
1988-06-20
Publications (2)
Publication Number
Publication Date
AU3651789A
AU3651789A
(en)
1989-12-21
AU612854B2
true
AU612854B2
(en)
1991-07-18
Family
ID=22777970
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU36517/89A
Ceased
AU612854B2
(en)
1988-06-20
1989-06-16
Novel neplanocin derivatives
Country Status (20)
Country
Link
EP
(1)
EP0347852B1
(en)
JP
(1)
JP2967998B2
(en)
KR
(1)
KR0139808B1
(en)
CN
(1)
CN1040031A
(en)
AR
(1)
AR244688A1
(en)
AT
(1)
ATE126800T1
(en)
AU
(1)
AU612854B2
(en)
CA
(1)
CA1339646C
(en)
DE
(1)
DE68923913T2
(en)
DK
(1)
DK301789A
(en)
ES
(1)
ES2078904T3
(en)
FI
(1)
FI91156C
(en)
GR
(1)
GR3017794T3
(en)
HU
(1)
HUT50194A
(en)
IE
(1)
IE66980B1
(en)
IL
(1)
IL90639A
(en)
NO
(1)
NO168108C
(en)
NZ
(1)
NZ229596A
(en)
PT
(1)
PT90903B
(en)
ZA
(1)
ZA894534B
(en)
Families Citing this family (13)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5521162A
(en)
*
1987-08-26
1996-05-28
Merrell Pharmaceuticals Inc.
Aristeromycin analogues of 4′,5′-didehydro-5′-fluoro-adenosine and methods of treating neoplastic and viral disease conditions
GB8815265D0
(en)
*
1988-06-27
1988-08-03
Wellcome Found
Therapeutic nucleosides
HU204843B
(en)
*
1988-09-27
1992-02-28
Merrell Dow Pharma
Process for producing 2′-halogen-methylidene adenosine derivatives and pharmaceutical compositions comprising same
JPH0421682A
(en)
*
1990-05-11
1992-01-24
Asahi Chem Ind Co Ltd
2-fluoroneplanocin a and its production
GB9205071D0
(en)
*
1992-03-09
1992-04-22
Wellcome Found
Therapeutic nucleosides
US5399580A
(en)
*
1993-03-08
1995-03-21
Burroughs Wellcome Co.
Therapeutic nucleosides-uses
GB9600142D0
(en)
*
1996-01-05
1996-03-06
Wellcome Found
Chemical compounds
CA2375383C
(en)
*
1999-06-09
2008-07-29
Anticancer, Inc.
Modulators of methylation for control of bacterial virulence
ATE490788T1
(en)
2003-04-25
2010-12-15
Gilead Sciences Inc
ANTIVIRAL PHOSPHONATE ANALOGUE
ME03423B
(en)
*
2004-07-27
2020-01-20
Gilead Sciences Inc
Phosphonate analogs of hiv inhibitor compounds
US8658617B2
(en)
2008-07-08
2014-02-25
Gilead Sciences, Inc.
Salts of HIV inhibitor compounds
CN102369204A
(en)
*
2008-09-26
2012-03-07
新加坡科技研究局
3-deazaneplanocin derivatives
SI3661937T1
(en)
2017-08-01
2021-11-30
Gilead Sciences, Inc.
Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) for treating viral infections
Family Cites Families (4)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
HU192741B
(en)
*
1978-05-25
1987-07-28
Toyo Jozo Kk
Process for producing new neplanocin antibiotics
DE3148363A1
(en)
*
1980-12-12
1982-09-16
Toyo Jozo K.K., Shizuoka
NEPLANOCIN A DERIVATIVES
GB2175588B
(en)
*
1985-04-15
1988-08-10
Toyo Jozo Kk
Nucleoside-phospholipid conjugates
DE3778626D1
(en)
*
1986-09-27
1992-06-04
Toyo Jozo Kk
NUCLEOSIDE PHOSPHOLIPID CONJUGATE.
1989
1989-06-14
ZA
ZA894534A
patent/ZA894534B/en
unknown
1989-06-16
IL
IL90639A
patent/IL90639A/en
not_active
IP Right Cessation
1989-06-16
NZ
NZ229596A
patent/NZ229596A/en
unknown
1989-06-16
AU
AU36517/89A
patent/AU612854B2/en
not_active
Ceased
1989-06-16
AR
AR89314191A
patent/AR244688A1/en
active
1989-06-19
PT
PT90903A
patent/PT90903B/en
not_active
IP Right Cessation
1989-06-19
NO
NO892543A
patent/NO168108C/en
not_active
IP Right Cessation
1989-06-19
HU
HU893137A
patent/HUT50194A/en
unknown
1989-06-19
FI
FI893003A
patent/FI91156C/en
not_active
IP Right Cessation
1989-06-19
IE
IE198689A
patent/IE66980B1/en
not_active
IP Right Cessation
1989-06-19
DK
DK301789A
patent/DK301789A/en
not_active
Application Discontinuation
1989-06-20
ES
ES89111230T
patent/ES2078904T3/en
not_active
Expired – Lifetime
1989-06-20
KR
KR1019890008457A
patent/KR0139808B1/en
not_active
IP Right Cessation
1989-06-20
CN
CN89104094A
patent/CN1040031A/en
active
Pending
1989-06-20
CA
CA000603455A
patent/CA1339646C/en
not_active
Expired – Fee Related
1989-06-20
DE
DE68923913T
patent/DE68923913T2/en
not_active
Expired – Fee Related
1989-06-20
EP
EP89111230A
patent/EP0347852B1/en
not_active
Expired – Lifetime
1989-06-20
JP
JP1155992A
patent/JP2967998B2/en
not_active
Expired – Fee Related
1989-06-20
AT
AT89111230T
patent/ATE126800T1/en
not_active
IP Right Cessation
1995
1995-10-18
GR
GR950402897T
patent/GR3017794T3/en
unknown
Also Published As
Publication number
Publication date
FI893003A
(en)
1989-12-21
DE68923913D1
(en)
1995-09-28
FI91156C
(en)
1994-05-25
FI91156B
(en)
1994-02-15
NO168108B
(en)
1991-10-07
CN1040031A
(en)
1990-02-28
NZ229596A
(en)
1990-12-21
IL90639A0
(en)
1990-01-18
JPH0240369A
(en)
1990-02-09
PT90903A
(en)
1989-12-29
ES2078904T3
(en)
1996-01-01
GR3017794T3
(en)
1996-01-31
IE66980B1
(en)
1996-02-21
CA1339646C
(en)
1998-01-27
PT90903B
(en)
1994-12-30
EP0347852A2
(en)
1989-12-27
FI893003A0
(en)
1989-06-19
NO168108C
(en)
1992-01-15
DK301789A
(en)
1989-12-21
AU3651789A
(en)
1989-12-21
NO892543L
(en)
1989-12-21
NO892543D0
(en)
1989-06-19
EP0347852A3
(en)
1991-09-11
ATE126800T1
(en)
1995-09-15
KR0139808B1
(en)
1998-06-01
IE891986L
(en)
1989-12-20
JP2967998B2
(en)
1999-10-25
IL90639A
(en)
1992-12-01
HUT50194A
(en)
1989-12-28
KR910000734A
(en)
1991-01-30
DK301789D0
(en)
1989-06-19
DE68923913T2
(en)
1996-01-11
EP0347852B1
(en)
1995-08-23
ZA894534B
(en)
1990-03-28
AR244688A1
(en)
1993-11-30
Similar Documents
Publication
Publication Date
Title
AU591564B2
(en)
1989-12-07
5-acylamino-pyrazole derivatives
AU2753588A
(en)
1989-06-29
New derivatives
AU5578390A
(en)
1990-10-11
Dioxothiazolidine derivatives
AU1741788A
(en)
1989-01-05
Azolylmethyl-cyclopropyl derivatives
AU4764990A
(en)
1990-07-19
3-Aryl-4-hydroxy-delta3-pyrroline-2-one derivatives
AU636155B2
(en)
1993-04-22
Thienodiazepine derivatives
AU6799990A
(en)
1991-06-20
2-iminopyridine derivatives
AU575745B2
(en)
1988-08-04
Alkylsulfonanilide derivatives
AU3301689A
(en)
1989-10-26
1-azabicyclo-alkyl derivatives
AU631896B2
(en)
1992-12-10
3-arylurail derivatives
AU2055488A
(en)
1989-04-20
7-Acylaminocephalosporin derivatives
AU612854B2
(en)
1991-07-18
Novel neplanocin derivatives
AU7596987A
(en)
1988-01-28
Novel 18-phenyloestrane derivatives
AU590687B2
(en)
1989-11-09
5-acylamino-pyrazole derivatives
AU2963389A
(en)
1989-08-03
Pyranobenzoxadiazole derivatives
AU2150088A
(en)
1989-03-02
Isoxazole-beta-carboline derivatives
AU6204690A
(en)
1991-03-07
Epiopodophyllotoxin altroside derivatives
AU616039B2
(en)
1991-10-17
Benzopyranol derivatives
AU573115B2
(en)
1988-05-26
2b-substituted thiomethylpenicillin derivatives
AU3315889A
(en)
1989-10-26
Phosphonoalkylpurine derivatives
AU4601389A
(en)
1990-06-14
Novel benzopyranylpyrrolinone derivatives
AU1862088A
(en)
1989-01-05
Hydroxyethyl-Azolyl derivatives
AU3330789A
(en)
1989-10-26
Arylpropanamine derivatives
AU3156989A
(en)
1989-09-28
Androst-4-ene derivatives
AU3301589A
(en)
1989-10-19
Oxadiazole-1-azabicyclo-alkane derivatives
Legal Events
Date
Code
Title
Description
2004-01-29
MK14
Patent ceased section 143(a) (annual fees not paid) or expired
